You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

Article metrics

Article menu

Download PDFPDF

Review
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019330
Jan 202025252
Feb 202010110134
Mar 202014414453
Apr 202012512529
May 202014914948
Jun 2020808019
Jul 2020737328
Aug 2020515127
Sep 202010310338
Oct 202012412451
Nov 202014915043
Dec 202012912927
Jan 202113213250
Feb 202113713732
Mar 202131931954
Apr 202130030081
May 202127927974
Jun 202123523539
Jul 202122422440
Aug 202122822845
Sep 202122422465
Oct 202126926981
Nov 202125425470
Dec 202124024261
Jan 202224625951
Feb 202222722841
Mar 202214915273
Apr 202211612355
May 2022888849
Jun 202212713250
Jul 202221321927
Aug 202223023229
Sep 202219119140
Oct 202219419946
Nov 202221521846
Dec 202216516744
Jan 202315415434
Feb 202315915937
Mar 202319219541
Apr 202314414446
May 202313113132
Jun 202313013020
Jul 202313413437
Aug 202314614734
Sep 202346947039
Oct 202331731725
Nov 202323823933
Dec 202318218449
Jan 202411812031
Feb 202417517538
Mar 202420820842
Total915592152180